St. Louis, MO, United States of America

Jeffery L Keene

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffery L. Keene

Introduction

Jeffery L. Keene is a prominent inventor based in St. Louis, MO, known for his significant contributions to the field of cancer treatment. With a total of 12 patents to his name, he has made remarkable strides in developing innovative therapies aimed at improving patient outcomes.

Latest Patents

Among his latest patents, one notable invention is a method of treating cancer that involves administering at least one active agent, including a thioredoxin reductase inhibitor and a glutathione depleting agent. This combination therapy aims to enhance the effectiveness of cancer treatment. Another significant patent focuses on pentaaza macrocyclic ring complexes that possess enhanced oral bioavailability. This invention includes a transition metal complex coordinated by a macrocycle, which is designed to improve the delivery of therapeutic agents.

Career Highlights

Jeffery L. Keene has established himself as a key figure in the pharmaceutical industry, particularly through his work at Galera Labs, LLC. His innovative approaches to cancer treatment have garnered attention and recognition within the scientific community.

Collaborations

Throughout his career, Keene has collaborated with notable colleagues, including Dennis Patrick Riley and Robert A. Beardsley. These partnerships have contributed to the advancement of his research and the development of groundbreaking therapies.

Conclusion

In summary, Jeffery L. Keene's work exemplifies the spirit of innovation in the field of cancer treatment. His patents and collaborations reflect a commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…